Skip to content

A Prospective Randomized Trial of Pancreatic Spontaneous Dislodgement Stents to Prevent Acute Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis

A Prospective Randomized Trial of Pancreatic Spontaneous Dislodgement Stents to Prevent Acute Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis - A Prospective Randomized Trial of Pancreatic Spontaneous Dislodgement Stents to Prevent Acute Post-ERCP Pancreatitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000003995
Enrollment
120
Registered
2010-08-05
Start date
2007-01-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-ERCP Pancreatitis

Interventions

stent group no stent group

Sponsors

Tokai University School of Medicine, Department of Gastroenterology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The study group consisted of patients at high risk for post-ERCP pancreatitis because of previous post-ERCP pancreatitis, sphincter of Oddi dysfunction (SOD), a difficult cannulation, the performance of pre-cut, pancreatic duct biopsy or IDUS, and a case requiring greater than 30 minutes in total examination.

Exclusion criteria

Exclusion criteria: We excluded younger patients than 20 years old and patients with pancreatitis due to gall stone.

Design outcomes

Primary

MeasureTime frame
The primary study endopoints were the frequency and severity of post-ERCP pancreatitis.

Secondary

MeasureTime frame
Further we evaluated hyperamylasemia, the success rate of stent placement, the duration of stent dislodgment and other complications in both groups.

Countries

Japan

Contacts

Public ContactYoshiaki Kawaguchi

Tokai University School of Medicine Gastroenterology

y711kawa@is.icc.u-tokai.ac.jp0463-93-1121

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026